Literature DB >> 25069089

Effects of traumatic brain injury on reactive astrogliosis and seizures in mouse models of Alexander disease.

Maria Luisa Cotrina1, Michael Chen2, Xiaoning Han2, Jeffrey Iliff2, Zeguang Ren2, Wei Sun2, Tracy Hagemann3, James Goldman4, Albee Messing3, Maiken Nedergaard2.   

Abstract

Alexander disease (AxD) is the only known human pathology caused by mutations in an astrocyte-specific gene, glial fibrillary acidic protein (GFAP). These mutations result in abnormal GFAP accumulations that promote seizures, motor delays and, ultimately, death. The exact contribution of increased, abnormal levels of astrocytic mutant GFAP in the development and progression of the epileptic phenotype is not clear, and we addressed this question using two mouse models of AxD. Comparison of brain seizure activity spontaneously and after traumatic brain injury (TBI), an effective way to trigger seizures, revealed that abnormal GFAP accumulation contributes to anomalous brain activity (increased non-convulsive hyperactivity) but is not a risk factor for the development of epilepsy after TBI. These data highlight the need to further explore the complex and heterogeneous response of astrocytes towards injury and the involvement of GFAP in the progression of AxD.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Astrocyte; Epilepsy; GFAP; Glia; Trauma

Mesh:

Substances:

Year:  2014        PMID: 25069089      PMCID: PMC4164594          DOI: 10.1016/j.brainres.2014.07.029

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  36 in total

1.  Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease model.

Authors:  Liqun Wang; Kenneth J Colodner; Mel B Feany
Journal:  J Neurosci       Date:  2011-02-23       Impact factor: 6.167

2.  Glial activation in a pilocarpine rat model for epileptogenesis: a morphometric and quantitative analysis.

Authors:  Felipe S Estrada; Vito S Hernández; Estela López-Hernández; Aleph A Corona-Morales; Hugo Solís; Alfonso Escobar; Limei Zhang
Journal:  Neurosci Lett       Date:  2012-02-25       Impact factor: 3.046

Review 3.  Interictal spikes: harbingers or causes of epilepsy?

Authors:  Kevin J Staley; Andrew White; F Edward Dudek
Journal:  Neurosci Lett       Date:  2011-03-31       Impact factor: 3.046

Review 4.  GFAP in health and disease.

Authors:  J Middeldorp; E M Hol
Journal:  Prog Neurobiol       Date:  2011-01-08       Impact factor: 11.685

5.  Early post-traumatic seizures in moderate to severe pediatric traumatic brain injury: rates, risk factors, and clinical features.

Authors:  Kate Liesemer; Susan L Bratton; C Michelle Zebrack; Douglas Brockmeyer; Kimberly D Statler
Journal:  J Neurotrauma       Date:  2011-04-21       Impact factor: 5.269

6.  Alexander disease.

Authors:  Albee Messing; Michael Brenner; Mel B Feany; Maiken Nedergaard; James E Goldman
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

Review 7.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

8.  Uniquely hominid features of adult human astrocytes.

Authors:  Nancy Ann Oberheim; Takahiro Takano; Xiaoning Han; Wei He; Jane H C Lin; Fushun Wang; Qiwu Xu; Jeffrey D Wyatt; Webster Pilcher; Jeffrey G Ojemann; Bruce R Ransom; Steven A Goldman; Maiken Nedergaard
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

9.  Cortical dysplasia with prominent Rosenthal fiber formation in a case of intractable pediatric epilepsy.

Authors:  Négar Khanlou; Gary W Mathern; Wendy G Mitchell; Noriko Salamon; Whitney B Pope; William H Yong; Harry V Vinters
Journal:  Hum Pathol       Date:  2009-05-08       Impact factor: 3.466

10.  GFAP mutations, age at onset, and clinical subtypes in Alexander disease.

Authors:  M Prust; J Wang; H Morizono; A Messing; M Brenner; E Gordon; T Hartka; A Sokohl; R Schiffmann; H Gordish-Dressman; R Albin; H Amartino; K Brockman; A Dinopoulos; M T Dotti; D Fain; R Fernandez; J Ferreira; J Fleming; D Gill; M Griebel; H Heilstedt; P Kaplan; D Lewis; M Nakagawa; R Pedersen; A Reddy; Y Sawaishi; M Schneider; E Sherr; Y Takiyama; K Wakabayashi; J R Gorospe; A Vanderver
Journal:  Neurology       Date:  2011-09-14       Impact factor: 11.800

View more
  6 in total

Review 1.  Alexander disease: models, mechanisms, and medicine.

Authors:  Tracy L Hagemann
Journal:  Curr Opin Neurobiol       Date:  2021-11-23       Impact factor: 6.627

2.  Machine Learning-Based Radiomics Predicting Tumor Grades and Expression of Multiple Pathologic Biomarkers in Gliomas.

Authors:  Min Gao; Siying Huang; Xuequn Pan; Xuan Liao; Ru Yang; Jun Liu
Journal:  Front Oncol       Date:  2020-09-11       Impact factor: 6.244

Review 3.  Protein biomarkers of epileptogenicity after traumatic brain injury.

Authors:  Denes V Agoston; Alaa Kamnaksh
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

4.  Alexander Disease Mutations Produce Cells with Coexpression of Glial Fibrillary Acidic Protein and NG2 in Neurosphere Cultures and Inhibit Differentiation into Mature Oligodendrocytes.

Authors:  Ulises Gómez-Pinedo; Maria Salomé Sirerol-Piquer; María Durán-Moreno; José Manuel García-Verdugo; Jorge Matias-Guiu
Journal:  Front Neurol       Date:  2017-06-06       Impact factor: 4.003

5.  A Process for Digitizing and Simulating Biologically Realistic Oligocellular Networks Demonstrated for the Neuro-Glio-Vascular Ensemble.

Authors:  Jay S Coggan; Corrado Calì; Daniel Keller; Marco Agus; Daniya Boges; Marwan Abdellah; Kalpana Kare; Heikki Lehväslaiho; Stefan Eilemann; Renaud Blaise Jolivet; Markus Hadwiger; Henry Markram; Felix Schürmann; Pierre J Magistretti
Journal:  Front Neurosci       Date:  2018-09-25       Impact factor: 4.677

Review 6.  15 Years MR-encephalography.

Authors:  Juergen Hennig; Vesa Kiviniemi; Bruno Riemenschneider; Antonia Barghoorn; Burak Akin; Fei Wang; Pierre LeVan
Journal:  MAGMA       Date:  2020-10-20       Impact factor: 2.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.